Atherosclerosis Clinical Trials

Find Atherosclerosis Clinical Trials Near You

Risk Prediction of Disease Progression in Early-Onset Coronary Atherosclerosis

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

This study is part of a nationwide research project in China that aims to better understand how coronary artery disease develops and progresses in young adults. The study will enroll approximately 10,000 participants aged 45 years or younger who undergo coronary CT scans at multiple hospitals across China. Information collected at enrollment includes basic health information, cardiovascular risk factors, blood test results, medication use, lifestyle habits, and, for some participants, genetic data. Participants will undergo follow-up coronary CT scans after several years to evaluate changes in coronary artery plaque and disease progression. By analyzing these clinical and imaging data, the study aims to identify factors associated with disease progression and to develop prediction models that may help estimate an individual's future risk of coronary plaque progression and cardiovascular events. The results of this study may contribute to improved risk assessment and early prevention strategies for coronary artery disease in young populations.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 45
Healthy Volunteers: f
View:

• Age between 18 and 45 years at the time of enrollment.

• Presence of symptoms suggestive of coronary artery disease and completion of coronary computed tomography (CT) examination.

• Ability and willingness to provide written informed consent and to participate in follow-up assessments.

Locations
Other Locations
China
FuWai hospital
RECRUITING
Beijing
Contact Information
Primary
Zhihui Hou, MD, PhD
konglingyihui@126.com
+86 15011451210
Time Frame
Start Date: 2025-01-01
Estimated Completion Date: 2028-01-01
Participants
Target number of participants: 10000
Related Therapeutic Areas
Sponsors
Leads: Fu Wai Hospital, Beijing, China

This content was sourced from clinicaltrials.gov